Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration

CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways

(2018) Shi-Tong Yu et al.   Cell Death & Disease

CXCR5-Overexpressing Mesenchymal Stromal Cells Exhibit Enhanced Homing and Can Decrease Contact Hypersensitivity

(2017) Xiaoran Zhang et al.   MOLECULAR THERAPY

Fibronectin protects lung cancer cells against docetaxel-induced apoptosis by promoting Src and caspase-8 phosphorylation

(2016) Sida Qin et al.   TUMOR BIOLOGY

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line

(2014) Faith Nutter et al.   ENDOCRINE-RELATED CANCER

Loss of E-Cadherin Expression Is Associated with a Poor Prognosis in Stage III Colorectal Cancer

(2014) Jung-A Yun et al.   ONCOLOGY

Alteration of Naïve and Memory B-Cell Subset in Chronic Graft-Versus-Host Disease Patients After Treatment With Mesenchymal Stromal Cells

(2014) Yanwen Peng et al.   Stem Cells Translational Medicine

Improvement in Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation upon Administration of Mesenchymal Stem Cells from Third-Party Donors: A Pilot Prospective Study

(2013) Xiaodan Liu et al.   CELL TRANSPLANTATION

Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis

(2013) Belen Fernandez-Garcia et al.   HISTOPATHOLOGY

Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer

(2013) Young Kyung Bae et al.   HUMAN PATHOLOGY

Oesophageal carcinoma

(2013) Arjun Pennathur et al.   LANCET

Immunohistochemical Study of Integrin α5β1, Fibronectin, and Bcl-2 in Normal Oral Mucosa, Inflammatory Fibroepithelial Hyperplasia, Oral Epithelial Dysplasia, and Oral Squamous Cell Carcinoma

(2013) Manuel Antonio Gordón Núñez et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Expression of Mesenchymal Markers Vimentin and Fibronectin: The Clinical Significance in Esophageal Squamous Cell Carcinoma

(2012) Tomoya Sudo et al.   ANNALS OF SURGICAL ONCOLOGY

Potentiation of tumor cell invasion by co-culture with monocytes accompanying enhanced production of matrix metalloproteinase and fibronectin

(2012) Go Kamoshida et al.   CLINICAL & EXPERIMENTAL METASTASIS

Classification of epithelial–mesenchymal transition phenotypes in esophageal squamous cell carcinoma is strongly associated with patient prognosis

(2011) Chang Ohk Sung et al.   MODERN PATHOLOGY

Assembly of Fibronectin Extracellular Matrix

(2010) Purva Singh et al.   Annual Review of Cell and Developmental Biology

Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion

(2010) Deshui Jia et al.   BMC CANCER

Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)

(2010) F. T. Martin et al.   BREAST CANCER RESEARCH AND TREATMENT

Relationship of Fibronectin and CD44v6 Expression with Invasive Growth and Metastasis of Liver Cancer

(2009) Rajiv K. Jha et al.   CANCER INVESTIGATION

Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression

(2009) Erika L. Spaeth et al.   PLoS One

IIICS de novo glycosylated fibronectin as a marker for invasiveness in urothelial carcinoma of the urinary bladder (UBC)

(2008) Petra Richter et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Stimulation of lung carcinoma cell growth by fibronectin–integrin signalling

(2008) Jeffrey D. Ritzenthaler et al.   Molecular BioSystems